Mirati Therapeutics We’re tackling cancer head-on At Mirati, we are relentlessly focused on developing best-in-class targeted therapies to meaningfully impact the lives of patients with cancer 1 2 3 Our Programs Mirati is developing a pipeline of novel therapeutics. Explore the Pipeline Become part of something bigger. Explore Careers at Mirati Press Releases 11/23/2021 Mirati Therapeutics to Participate in the 4th Annual Evercore ISI HealthCONx Conference 11/22/2021 Mirati Therapeutics and Verastem Oncology Partner to Evaluate Adagrasib in Combination with VS-6766 in KRASG12C-Mutant Non-Small Cell Lung Cancer 11/17/2021 Mirati Therapeutics Announces Submission of Investigational New Drug Application to U.S. Food and Drug Administration of MRTX1719 to Treat MTAP-Deleted Cancers 11/10/2021 Mirati Therapeutics Announces Pricing of Public Offering of Common Stock View all press releases Mirati Therapeutics © Copyright 2021 - Mirati Therapeutics, Inc. 858.332.3410 info@mirati.com Terms of Use Privacy Cookies Expanded Access Community Guidelines Close this module About Cookies on This Site Essential and functional cookies are necessary for the proper functioning of this website and cannot be refused. Other cookies are used for statistical purposes and will only be placed if you agree to their placement. For further details on cookies, how we use cookies and how to modify your choices regarding cookies, please read our Cookies Policy. Accept

Mirati Therapeutics Executive Leadership Our Aspirations for Excellence Start with Our Leadership David Meek Chief Executive Officer and Board Director Charles Baum, M.D., Ph.D. President, Founder and Head of Research & Development, and Board Member James Christensen, Ph.D. Chief Scientific Officer Reena Desai General Counsel and Corporate Secretary Kristin Gustafson Chief Human Resources Officer Ben Hickey Chief Commercial Officer Vickie Reed Chief Accounting Officer Meet our Board of Directors Faheem Hasnain Chairman Charles Baum, M.D., Ph.D. Director Bruce Carter, Ph.D. Director Julie Cherrington, Ph.D. Director Aaron Davis Director Henry Fuchs, M.D. Director Craig Johnson Director Maya Martinez-Davis Director David Meek Director Shalini Sharp Director Mirati Therapeutics © Copyright 2021 - Mirati Therapeutics, Inc. 858.332.3410 info@mirati.com Terms of Use Privacy Cookies Expanded Access Community Guidelines Close this module About Cookies on This Site Essential and functional cookies are necessary for the proper functioning of this website and cannot be refused. Other cookies are used for statistical purposes and will only be placed if you agree to their placement. For further details on cookies, how we use cookies and how to modify your choices regarding cookies, please read our Cookies Policy. Accept